Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $6.7 million.

  • Rockwell Medical's Cash from Financing Activities rose 19156.94% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 11245.41%. This contributed to the annual value of $7.3 million for FY2024, which is 3521.42% down from last year.
  • As of Q3 2025, Rockwell Medical's Cash from Financing Activities stood at $6.7 million, which was up 19156.94% from -$650000.0 recorded in Q2 2025.
  • Rockwell Medical's Cash from Financing Activities' 5-year high stood at $26.8 million during Q2 2022, with a 5-year trough of -$6.0 million in Q4 2022.
  • Over the past 5 years, Rockwell Medical's median Cash from Financing Activities value was -$339500.0 (recorded in 2021), while the average stood at $2.1 million.
  • In the last 5 years, Rockwell Medical's Cash from Financing Activities crashed by 16230000.0% in 2021 and then skyrocketed by 44715000.0% in 2022.
  • Rockwell Medical's Cash from Financing Activities (Quarter) stood at -$1.6 million in 2021, then plummeted by 268.47% to -$6.0 million in 2022, then skyrocketed by 87.6% to -$742000.0 in 2023, then soared by 476.28% to $2.8 million in 2024, then soared by 141.55% to $6.7 million in 2025.
  • Its Cash from Financing Activities stands at $6.7 million for Q3 2025, versus -$650000.0 for Q2 2025 and -$783000.0 for Q1 2025.